Handa Pharmaceuticals, Inc. is a specialty pharmaceutical company focused on the development of niche portfolios. The company’s business strategy comprises of utilizing our Taiwan headquarters as our global R&D center and establishing our presence in the world’s two largest pharmaceutical markets (the US and China).
Handa Pharma integrates its own pharmaceutical development platform with patent analysis, regulatory affairs, and market planning to focus on the development of high-barrier/patentable niche products, including:
- 505(b)(2) New drug development
- High barrier/patentable generics development